Credit: Provided by Rice University
Summary:
Study suggests new drug strategy for insulin-influenced tumor growth
Full Text:
Drugs that target insulin pathways to slow or stop the growth of brain tumors are going in the right direction but appear to be on the wrong track, according to new research. Through detailed computer models and experiments on two distinct glioblastoma cell types, researchers have found reason to believe therapies that attack the insulin signaling pathway thought to influence tumor development have had mixed results in trials because they go after the wrong targets.
